William P Sheridan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William P Sheridan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William P Sheridan. William P Sheridan is Senior VP - CMO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and SR VP - CMO in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Latest Insider Trading Transactions of William P Sheridan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 11.17 | 5,074 | 56,677 | 95,609 | 100.7 K to 95.6 K (-5.04 %) |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 12.16 | 52,000 | 632,320 | 52,000 | |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 12.16 | 2,735 | 33,258 | 100,683 | 103.4 K to 100.7 K (-2.64 %) |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Grant | A | 0.00 | 10,900 | 0 | 103,418 | 92.5 K to 103.4 K (+11.78 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 1.42 | 23,104 | 32,808 | 62,500 | |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 1.42 | 14,396 | 20,442 | 85,604 | |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 5.45 | 17,000 | 92,650 | 0 | |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 5.45 | 17,000 | 92,650 | 0 | |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 12.06 | 23,104 | 278,634 | 92,518 | 115.6 K to 92.5 K (-19.98 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.42 | 23,104 | 32,808 | 115,622 | 92.5 K to 115.6 K (+24.97 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 12.43 | 105,295 | 1,308,817 | 92,518 | 197.8 K to 92.5 K (-53.23 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.42 | 14,396 | 20,442 | 197,813 | 183.4 K to 197.8 K (+7.85 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 5.45 | 17,000 | 92,650 | 183,417 | 166.4 K to 183.4 K (+10.22 %) |
| Dec 31 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 5.45 | 17,000 | 92,650 | 166,417 | 149.4 K to 166.4 K (+11.38 %) |
| Dec 23 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 4.73 | 3,427 | 16,210 | 46,573 | |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 6.68 | 4,051 | 27,061 | 59,949 | |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 4.15 | 13,750 | 57,063 | 41,250 | |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 9.86 | 1,644 | 16,210 | 148,173 | 149.8 K to 148.2 K (-1.10 %) |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 4.73 | 3,427 | 16,210 | 149,817 | 146.4 K to 149.8 K (+2.34 %) |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 9.86 | 2,745 | 27,066 | 146,390 | 149.1 K to 146.4 K (-1.84 %) |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 6.68 | 4,051 | 27,061 | 149,135 | 145.1 K to 149.1 K (+2.79 %) |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 9.86 | 5,788 | 57,070 | 145,084 | 150.9 K to 145.1 K (-3.84 %) |
| Jun 05 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 4.15 | 13,750 | 57,063 | 150,872 | 137.1 K to 150.9 K (+10.03 %) |
| May 28 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Payment of Exercise | F | 11.69 | 1,739 | 20,329 | 137,122 | 138.9 K to 137.1 K (-1.25 %) |
| Feb 04 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 10.80 | 35,000 | 378,000 | 35,000 | |
| Feb 04 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 54,000 | 0 | 136,539 | 82.5 K to 136.5 K (+65.42 %) |
| Jan 03 2014 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Payment of Exercise | F | 7.60 | 2,735 | 20,786 | 82,539 | 85.3 K to 82.5 K (-3.21 %) |
| May 29 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | M | 1.20 | 16,407 | 19,688 | 0 | |
| May 29 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Buy | M | 1.20 | 16,407 | 19,688 | 82,274 | 65.9 K to 82.3 K (+24.91 %) |
| Mar 14 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 1.38 | 3,000 | 4,140 | 67,656 | 64.7 K to 67.7 K (+4.64 %) |
| Mar 06 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Payment of Exercise | F | 1.19 | 1,789 | 2,129 | 62,867 | 64.7 K to 62.9 K (-2.77 %) |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 1.42 | 50,000 | 71,000 | 50,000 | |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 1.42 | 50,000 | 71,000 | 50,000 | |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 8,500 | 0 | 64,656 | 56.2 K to 64.7 K (+15.14 %) |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 8,500 | 0 | 56,156 | 47.7 K to 56.2 K (+17.84 %) |
| Mar 19 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Payment of Exercise | F | 5.23 | 7,543 | 39,450 | 44,656 | 52.2 K to 44.7 K (-14.45 %) |
| Mar 19 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 22,869 | 0 | 52,199 | 29.3 K to 52.2 K (+77.97 %) |
| Mar 12 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 5.59 | 100,000 | 559,000 | 100,000 | |
| Mar 05 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Option Exercise | A | 4.73 | 50,000 | 236,500 | 50,000 | |
| Mar 05 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Sell | S | 4.78 | 956 | 4,570 | 29,330 | 30.3 K to 29.3 K (-3.16 %) |
| Mar 05 2012 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | SR VP - CMO | Grant | A | 0.00 | 8,500 | 0 | 30,286 | 21.8 K to 30.3 K (+39.02 %) |
Page: 1